Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C, Teufel A, Yevsa T, Staib F, Hohmeyer A, Walenda G, Zimmermann HW, Vucur M, Huss S, Gassler N, Wasmuth HE, Lira SA, Zender L, Luedde T, Trautwein C, Tacke F.
Schneider C, et al. Among authors: tacke f.
Gut. 2012 Dec;61(12):1733-43. doi: 10.1136/gutjnl-2011-301116. Epub 2012 Jan 20.
Gut. 2012.
PMID: 22267597
Free PMC article.